Thick Tumor Fluid May Make Glioblastoma Cells Smaller, More Flexible and Better at Invading Tissue

For a month, researchers in Chongqing, China, kept human brain cancer cells in a fluid thicker than the one their cells normally sit in. They were testing an idea that runs against intuition: that a more resistant environment might not slow glioblastoma cells down but change them.

Glioblastoma is a deadly brain cancer, and cancer research has mostly focused on chemical signals and on how stiff the surrounding tissue is. Much less attention has gone to the viscosity of the fluid cells move through. In glioblastoma the difference is large. Fluid at the tumor's advancing edge is about eight times more viscous than fluid in the dead tissue at its center, so cells moving outward push through an increasingly resistant medium.

That has been hard to study. Conventional closed microfluidic devices can restrict oxygen and nutrients inside their enclosed channels, and friction against the channel walls adds forces that muddy the results. They also make it hard to watch how cells respond to long exposure to thick fluid.

Scientists from Chongqing General Hospital and Chongqing University built a different tool, described in Microsystems & Nanoengineering. It is a two-layer open microfluidic membrane with a removable cap and an array of tiny pillars. The cap lets the team control exactly when cells start migrating, and the pillars create narrow gaps so they can watch nuclei change shape as cells squeeze through. Because the platform is open, cells can be cultured continuously for up to one month.

The team tested two human glioblastoma cell lines, U-251 and LN-229. Each was grown for a month in a fluid meant to mimic the tumor's invasive edge, at 7.1 cP. On the chip, the adapted cells traveled faster and farther than untreated controls, a surprising result given that thicker fluid would be expected to impede movement.

Microscopy suggested how. After prolonged exposure, the cells were smaller and easier to deform, which let them pass between the pillars. Their nuclei visibly deformed during the squeeze, and the protein YAP, which helps cells sense mechanical force, accumulated inside the nuclei, a recognized sign that stress-response pathways were active.

The two cell lines reached similar shapes and speeds by different molecular routes. U-251 cells showed a mesenchymal-like reprogramming, switching on invasion-linked genes including CD44, FN1 and MMP9. LN-229 cells became more flexible and mobile without substantial lasting changes in gene expression. Western blot analysis found that protein changes remained detectable even after cells were moved back into fluid of normal viscosity, so at least some of the adaptation persisted. The researchers describe this as a form of mechanical memory: cells keeping changes from earlier physical stress after the stress is gone. They had expected viscosity to act mainly as an obstacle.

The team also sees the chip as a testing platform. It fits standard multi-well plates, allows direct staining and long-term observation, and avoids the clogging seen in closed systems. That could suit drug tests aimed at YAP signaling or at remodeling of the cytoskeleton, the internal framework that shapes cells. The approach might also apply to other cancers where fluid viscosity varies across regions, and could help identify patients whose tumors rely on mechanical adaptation to spread.

The work was done on cell lines in the lab, and the authors note that more research is needed to learn how the findings translate to tumors in patients. Funding came from several Chinese national and provincial sources, including the National Natural Science Foundation of China. The next step is to see whether drugs aimed at these mechanical pathways work under tumor-like conditions.